Unknown Manufacturer
BMS-863233 has been investigated for the treatment of Refractory Hematologic Cancer.
BMS-863233 has been investigated for the treatment of Refractory Hematologic Cancer.
One entry per invention. Patent families filed in the US, EP, WO and CN offices.
No patents found under this name
Patent documents usually refer to a drug by its chemical name or development code rather than its generic name, and applications are only published about 18 months after filing — so a newer drug may not appear here yet.
